Bevacizumab combined with chemotherapy for ovarian cancer: A protocol for systematic review and meta-analysis

BACKGROUND: The impact of bevacizumab (an anti-vascular endothelial growth factor therapy) remains uncertain, which has been the focus of studies on the management of ovarian cancer (OC). We performed a protocol for systematic review and meta-analysis to assess the efficacy and safety of bevacizumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Ting, Li, Li, Wang, Liya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5600
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702237/
https://www.ncbi.nlm.nih.gov/pubmed/34941162
http://dx.doi.org/10.1097/MD.0000000000028376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702237/
https://www.ncbi.nlm.nih.gov/pubmed/34941162
http://dx.doi.org/10.1097/MD.0000000000028376

Ejemplares similares